Anticoagulants Market is poised to register a CAGR of 7.5% during the forecast period 2022 to 2028.

Anticoagulant medicines (also known as blood thinners) are chemical agents that inhibit or diminish blood coagulation and lengthen the time it takes for blood to clot. These medications are mostly used in patients with a high risk of blood clots in illnesses such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others. The global anticoagulants industry is expected to grow significantly during the forecast period, owing to an increase in the prevalence of venous thromboembolism (VTE) and cardiovascular disorders, increased adoption of novel oral anticoagulants (NOACs), and increased awareness of NOACs in the developing region. Furthermore, an increase in the number of obese and aged individuals, increased unmet requirements, and a surge in demand for innovative therapies all contribute to market growth. However, the greater price of NOACs and the absence of NOAC antidotes restrict market expansion.

This is due to a rise in the prevalence of chronic illnesses as well as technological breakthroughs in the production of anticoagulant products. Anticoagulants are used to treat and prevent blood clots, which can block blood vessels (an artery or a vein) and cause significant consequences such as heart attack and stroke because the clot restricts the flow of blood to vital organs.

Furthermore, technical progress in the creation of anticoagulant products is projected to drive the market. According to the study ""Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing,"" published in the Frontier in Biotehnology and Bioengineering, advanced technologies such as microfluidics, fluorescent microscopy, electrochemical sensing, photoacoustic detection, and micro/nano electromechanical systems (MEMS/NEMS) have been used to develop highly accurate, robust, and cost-effective anticoagulant products.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Anticoagulants Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Anticoagulants Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Anticoagulants Market:
• Bayer AG
• Aspen Holdings
• Boehringer Ingelheim GmbH
• Daiichi Sankyo Company, Limited
• Bristol-Myers Squibb Company
• GlaxoSmithKline
• Pfizer, Inc.
• Sanofi S.A.
• Johnson & Johnson
• Portola Pharmaceuticals, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Anticoagulants Market Segmentation:
By Drug Class
   o Bevyxxa
   o Eliquis
   o Lixiana and Savaysa
   o Pradaxa
   o Xarelto
• Heparin and LMWH
• Vitamin K Antagonist
• Others
By Route of Administration
• Injectable Anticoagulant
• Oral Anticoagulant
By Application
• Stroke
• Atrial Fibrillation
• Pulmonary Embolism (PE)
• Deep vein thrombosis (DVT)
• Others

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Respiratory Care Devices Market Video Sample:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Anticoagulants Market By Drug Class, By Route of Administration, By Distribution Channel, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics